AI Article Synopsis
- Comparing genetic mutations in first-degree relatives of patients with appendiceal pseudomyxoma peritonei could offer insights into how the disease develops and its clinical outcomes.
- Molecular profiling of these mucinous tumors might help in discovering better treatment options compared to current chemotherapy methods.
- Understanding the genetic factors may enhance personalized treatment strategies for affected individuals.
Article Abstract
Comparing genetic mutations of first-degree relatives with appendiceal pseudomyxoma peritonei may explain clinical outcomes and disease pathogenesis. Molecular profiling of mucinous tumors may identify improved treatments to traditional chemotherapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752445 | PMC |
| http://dx.doi.org/10.1002/ccr3.3338 | DOI Listing |
Publication Analysis
Top Keywords
first-degree relatives
8
relatives appendiceal
8
germline somatic
4
somatic genetic
4
genetic alterations
4
alterations first-degree
4
appendiceal low-grade
4
low-grade mucinous
4
mucinous carcinoma
4
carcinoma peritonei
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!